Trial Profile
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATOC (Primary)
- Indications Colorectal cancer; Lung cancer; Neuroendocrine tumours; Pancreatic cancer
- Focus Diagnostic use
- 20 Jan 2020 Status changed from suspended to completed.
- 09 Aug 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Sep 2019.
- 09 Aug 2019 Status changed from recruiting to suspended.